FDA investigation

FDA
Favicon Fierce Pharma

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

The agency is investigating two Duchenne muscular dystrophy patient deaths following treatment with Sarepta Therapeutics’ Elevidys.
Angus Liu Jun 25, 2025 10:26am
FDA Building

Cassava scores a win as FDA declines to halt Alzheimer's trials

Feb 11, 2022 9:34am
head shot photo of Robert Califf MD

At the eleventh hour, Califf becomes FDA commish nominee

Nov 12, 2021 10:32am